By Ed Coghlan
What should make chronic pain patients smile is the news that the federal government is actually allowing more research of the impact that medical cannabis has in chronic illness.
The National Institute on Drug Abuse (NIDA) recently awarded a team of scientific researchers at the University of Florida a $3.2 million grant in order to determine whether the plant medicine will alleviate ailments caused by the human immunodeficiency virus (HIV).
Newsweek reported a story that the National Pain Report has been emphasizing for several years—that the federal drug laws are hampering legitimate research on the medical impact cannabis can have on several chronic illnesses including chronic pain.
Since marijuana is still a Schedule 1 substance, it’s difficult to get clinical studies approved by the U.S. Food and Drug Administration (FDA).
The catch here is that in the absence of enough federally funded research, marijuana proponents lack the grounds for getting the Schedule 1 classification overturned.
The Las Vegas Sun printed a story that indicates many veterans are overwhelmingly in favor of research of the impact medical cannabis has for treating mental or physical conditions. 82% said they wanted cannabis as a federally legal treatment option.
The added negative influence of Attorney General Sessions who continues to proclaim his belief that marijuana should not be legalized—that it leads to worse drug use and crime.
That’s despite the growing public support for the legalization of cannabis, although for it to break through as a serious and universally accepted way to treat chronic pain, it simply will need more serious research results.
The growing cannabis industry is seeing an opportunity in the opioid issue.
It released a survey this past week that claims that 67% of patients stopped using opioid medications after using medical cannabis.
The preliminary study was released by Aclara Research which is a firm that specializes in the cannabis industry and said that the study was with a group of pharmacist professionals active within the cannabis industry.
29 states and the District of Columbia have legalized marijuana in some form—most of them for medical use.